Experimental and Molecular Pathology

4.3k papers and 92.0k indexed citations i.

About

The 4.3k papers published in Experimental and Molecular Pathology in the last decades have received a total of 92.0k indexed citations. Papers published in Experimental and Molecular Pathology usually cover Molecular Biology (1.7k papers), Oncology (634 papers) and Cancer Research (620 papers) specifically the topics of Liver Disease Diagnosis and Treatment (168 papers), Cancer-related molecular mechanisms research (159 papers) and MicroRNA in disease regulation (145 papers). The most active scholars publishing in Experimental and Molecular Pathology are James W. Lillard, Rajesh Singh, Samuel W. French, Richard O. Recknagel, Henry Z. Movat, Neil V.P. Fernando, William E. Stehbens, John Neustadt, K. Suryanarayana Rao and Fawzia Bardag‐Gorce.

In The Last Decade

Fields of papers published in Experimental and Molecular Pathology

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers published in Experimental and Molecular Pathology. Nodes represent fields, and links connect fields that are likely to share authors.

Countries where authors publish in Experimental and Molecular Pathology

Since Specialization
Total citations of papers

This map shows the geographic distribution of research published in Experimental and Molecular Pathology. It shows the number of citations received by papers published by authors working in each country. You can also color the map by specialization and compare the number of papers published in Experimental and Molecular Pathology with the expected number of papers based on a country's size and research output (numbers larger than one mean the country's share of papers is larger than expected).

Rankless by CCL
2025